Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
103
天
Circulating biomarkers and polygenic scores for cardiovascular risk prediction in healthy older adults: differential and complementary contributions
作者
Chenglong Yu; Cammie Tran; Johannes T. Neumann; Le T.P. Thao; Peter D. Fransquet; Sultana Monira Hussain; Christopher M. Reid; Mark R. Nelson; Robyn L. Woods; Michael Berk; Stefan Blankenberg; Andrew M. Tonkin; John J. McNeil; Paul Lacaze展开收起
作者单位
School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia; Victorian Heart Institute, Monash University, Clayton, Victoria, Australia; Department of Cardiology, University Heart & Vascular Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Cardiovascular Research (DZHK), Partner Site North, Germany; School of Population Health, Curtin University, Perth, Western Australia, Australia; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia; The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Victoria, Australia; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia展开收起
98
天
Long-term average atherogenic index of plasma and cardiovascular mortality in 8.9 million Korean adults: A nationwide cohort study
作者
Hyeon Hui Kang; Yoonjong Bae; Hoseob Kim; Ki-Bum Won展开收起
作者单位
Department of Internal Medicine, Clinical Trial Dossier Evaluation Division, Ministry of Food and Drug Safety, Gwacheon, Republic of Korea; Department of Data Science, Hanmi Pharm Co Ltd, Seoul, Republic of Korea; Department of Internal Medicine, Division of Cardiology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Republic of Korea展开收起
125
天
Real-world variability and factors associated with individual low-density-lipoprotein cholesterol response to different doses of atorvastatin, rosuvastatin, and simvastatin in 28,647 Chinese patients
作者
Yuexi Liao; Wai Ki Keith Cheung; Ralph K. Akyea; Brian Tomlinson; Celine SL. Chui; Joseph Edgar Blais展开收起
作者单位
Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region of China; School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region of China; Precision Healthcare and Drug Safety (PRISM) Research Group, Centre for Academic Primary Care, School of Medicine, University of Nottingham, Nottingham, UK; School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, China展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天